Tohoku Medical and Pharmaceutical University · Unclassified · 講師

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Fibronectin-LILRB4/gp49B interaction negatively regulates osteoclastogenesis through inhibition of RANKL-induced TRAF6/TAK1/NF-kB/MAPK signaling.
• Deletion of N-myc downstream-regulated gene 2 attenuates reactive astrogliosis and inflammatory response in a mouse model of cortical stab injury
• Behavioral stress and antidepressant treatments altered hippocampal expression of Nogo signal-related proteins in rats
• Impact of the COVID‐19 pandemic on patients with bipolar disorder in Japan

• 神経系の発達と精神疾患の発症における抑制型免疫レセプターgp49Bの機能解析
• 免疫調整因子LILRB4を標的とする全身性エリテマトーデス/ループス腎炎の新規治療薬の創出
• 母体免疫活性に由来する精神疾患に対して抑制型免疫レセプターはどのように機能するか

• Official profile
• ORCID